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Despite the potential of antibody-coated nanoparticles (Ab-NPs) in many biological applications, there are
very few successful, commercially available examples in which the carefully engineered nanomaterial has
made it beyond the laboratory bench. Herein we explore the robustness and cost of protein-nanoparticle
conjugation. Using multivalent polyamidoamine (PAMAM) dendrimers and dextran as crosslinkers, it was
possible to retain colloidal stability during (i) NP-linker binding and (ii) the subsequent conjugation reaction
between linker-coated NPs and proteins to generate monodisperse Ab-NPs. This was attributed to the
physicochemical properties of the linkers, which were inherited by the NPs and thus beneﬁted colloidal
stability. Attaching negatively charged, EDC/sulfo-NHS-activated PAMAM to the NPs contributed to overall
negative charge of particles, and in turn led to high electrostatic attraction between the protein and
PAMAM-coated NPs during the reaction conditions. In contrast, using an uncharged, EDC/NHS-activated
PAMAM dendrimer led to NP aggregation and lower protein binding eﬃciency. Dextran as a cost-eﬀective,
uncharged macromolecule allowed for steric repulsions between neighbouring particles during protein
binding, thus inducing NP stability in solution, and also produced monodisperse Ab-NPs. By freeze-drying
Ab-NPs from a 1% BSA solution it is possible to reconstitute the solid-form colloid back to a stable state by
adding solvent and simply shaking the sample vial by hand. The consequences of the diﬀerent surface
chemistries and freeze-drying stabilizers on the colloidal stability of the NPs were probed by dynamic light
scattering. The performance of Ab-NPs was compared in a simple ﬂuorescence linked immunoassay in
whole serum. Interestingly, the signal-to-noise ratios were similar for Ab-NPs using PAMAM and dextran,
despite dextran binding fewer Abs per NP. We believe this work provides researchers with the tools and
strategies for reliably generating Ab-NPs that can be used for a variety of biological applications.Introduction
The rapid growth in nanotechnology research over the past two
decades has led to the development of a ‘nano-Particle Zoo’,Kent and Greenwich, Chatham, Kent, UK.
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hemistry 2015housing a myriad of nanomaterials (such as nanoparticles,
nanotubes, nanoclusters, nanobubbles, nanostars etc.) with
exciting ranges of properties. Though these materials can
sometimes be diﬃcult to predictably engineer,1–3 many have
shown highly desirable characteristics for industrial applica-
tions that promise to inuence our daily lives.4–6 Unfortunately,
very few have been converted from the laboratory benchtop into
commercial success. Importantly, two provocatively-titled
contributions by Juliano7 and Venditto8 outstandingly describe
the diﬃcult path for the clinical development of nanoparticle-
based therapies and warned against ‘overpromising’ the bene-
ts of this technology. This slow progress can be attributed to a
number of factors, however some stand out as major stumbling
blocks: (i) lack of robustness and reproducibility in nanoparticle
surface functionalization, (ii) the use of expensive, specialized
reagents (iii) inadequate protocols for the nanomaterial
handling that result in excessive manipulation of the samples
by the end-user and (iv) limited scope for large scale production.
Herein we attempt to address the rst three issues by eﬃcientlyJ. Mater. Chem. B, 2015, 3, 2043–2055 | 2043
Fig. 1 (a) Cartoons of proteins used in this study, their corresponding
size and known isoelectric points (pI); (b) magniﬁcation of the NP-core
showing FITC molecule covalently bound inside the silica matrix. The
two steps required to tether antibodies to the NP surface: (Step 1) NP
functionalization with crosslinker followed by (Step 2) the attachment
of the biomolecule to the linker-coated NP; (c) cartoon representation
of idealized and commonly drawn antibodies on NP surface compared
to a more realistic scenarios.
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View Article Onlinegenerating colloidally stable antibody-coated uorescent silica
nanoparticles (Ab-NP) through the use of multivalent linker
molecules.
The most common method of antibody-nanoparticle conju-
gation is through covalent bond formation via a linker mole-
cule. The use of a linker creates a space between the protein and
the nanoparticle surface, thus avoiding biomolecule denatur-
ation or undesirable biomolecule–nanoparticle interactions.
One of the major problems with the published protocols
describing the bioconjugation reactions with nanoparticles is
that they ignore the eﬀect of the crosslinker introduction, which
alters the surface chemistry of a given colloid and oen leads to
particle aggregation. Conventional colloid science prevents
aggregation of ‘plain’ NPs by introducing capping agents to the
NP surface or by tailoring surface charges to separate NPs via
electrostatic repulsions.9
Bagwe et al.10 for example, preserved the colloidal stability of
silica nanoparticles by coating their surface with ‘chemically
inert’, negatively charged phosphonates alongside ‘reactive’
–NH2 groups. There has, however, been little focus on how the
characteristics of the crosslinker inuence nanoparticle
stability, and whether this, in turn, can play a role in antibody
binding eﬃciency and Ab-NP polydispersity.
Generating Ab-NPs is usually a two-step process: the
attachment of crosslinkers to the ‘plain’ NP surface (Fig. 1b,
Step 1), followed by the attachment of antibodies to the NPs via
the crosslinker (Fig. 1b, Step 2). It is sensible to assume that
sample monodispersity is required throughout these steps and
appears to be a natural extension of conventional methods of
inhibiting ‘plain’ NP aggregation. This implies that linker's
physiochemical properties must be carefully considered before
performing the chemical reactions. The lack of attention paid to
this issue is surprising, especially when the nanoparticle size
and its surface properties are considered to be the two most
important parameters for the mediation of biocompatibility of
new material used in nanomedicine.11 This view was reinforced
in several excellent reviews by Stellacci,12 Tan13 and Thomp-
son,14 in which the authors summarized the main forces gov-
erning the interfacial interactions between nanoparticles and a
variety of biological systems. Previously, we showed the benets
of multivalent, hyperbranched polyamidoamine (PAMAM)
dendrimers as crosslinkers.15 The use of such macromolecules
improved antibody binding eﬃciency and subsequently
enhanced Ab-NP binding kinetics in immunoassays.16 Persist-
ing with this multivalent approach, we have reviewed and
further optimized the surface conjugation strategies to gra full
size model proteins (goat anti-human IgG and bovine serum
albumin (BSA)) and also single chain antibody fragments
(recombinant anti-C-reactive protein ScFv) onto the surface of
dye-doped silica NPs. We have employed three diﬀerent multi-
valent crosslinkers: generation 4.5 PAMAM dendrimer and two
additional inexpensive macromolecules: 40 kDa dextran and
BSA (Scheme 1). Dextran and BSA are more than 10 times less
expensive than PAMAM dendrimers and therefore contribute to
the reduction of the cost of generating Ab-NPs. The diﬀerent
multivalent linkers present important consequences on the
colloidal stability of the NPs and are accountable for the overall2044 | J. Mater. Chem. B, 2015, 3, 2043–2055eﬃciency and robustness of the bioconjugation protocols. The
prepared antibody-coated nanoparticles were scrutinized in a
simple uorescence-linked immunoassay to qualitatively assess
their active surface area (i.e. area of the nanoparticle surface
that is covered with antibodies in their active state). We also
highlight the misleading depictions of Ab-NPs in many articles
that regularly show tethered antibodies oriented such that their
epitopes are free and available for binding. Although the
scenario of predominantly randomly positioned antibodies on
the particle surface is more realistic and appropriate (Fig. 1c),
many scientists opt to use the ‘ideal’ and quite unrealistic
illustrations. For this reason, we stress the importance of Ab-
NP's ‘active surface area’ throughout this article. Importantly,
we have also investigated the eﬀect of cryoprotectants17 during
freeze-drying to improve the long-term storage and colloidal
stability upon re-constitution of Ab-NPs. Apart from the tradi-
tional sugar-based protectants, we have also used BSA in an
attempt to reduce the diﬀerent physical and chemical factors
that may destabilize the system, notably the freezing and
dehydration stresses during the phase separation into ice andThis journal is © The Royal Society of Chemistry 2015
Scheme 1 Crosslinkers used in the bioconjugation.
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View Article Onlinecryo-concentrated solution. Two commonly available analytical
techniques, dynamic light scattering and uorescence spectro-
photometry, were used to characterize and analyze the prepared
nanomaterials. Other techniques such as transmission electron
microscopy, scanning electron microscopy, and confocal scan-
ning laser microscopy have been used to support and corrobo-
rate the results.Results and discussion
Using G4.5 PAMAM for bioconjugation optimization
Dye-doped silica nanoparticles were prepared using a well-
known, reverse microemulsion method. The synthesis was
adapted from Bagwe et al.10 The synthetic protocol includes a
nanoparticle surface modication step using siloxane deriva-
tives with both ‘inert’ phosphonate groups and ‘reactive’ amino
groups in a 10 : 1 ratio (Fig. 1b). Such specic composition of
the NP-shell displays unique electrostatic properties (strongly
negative zeta potential and relatively low isoelectric point), due
to which the colloid maintains its stability in aqueous solutions.
Because of the limited amount of the reactive amino groups on
the NP surface, multivalent linkers are employed to increase the
number of potential binding sites for biomolecule attachment.
We have previously reported on the eﬀects of diﬀerent half-
generations of PAMAM dendrimer with COOH surface groups to
couple proteins onto silica nanoparticles.16,18 To successfullyThis journal is © The Royal Society of Chemistry 2015perform this reaction, the COOH groups of the crosslinker must
be activated. This activation is routinely accomplished using a
mixture of NHS/EDC to convert the carboxylic acids to amine-
reactive NHS-esters. Such activated dendrimer is added in large
excess (106 PAMAM : 1 NP) to the NP solution to avoid
unwanted cross-linking of individual particles. As illustrated in
Scheme 1, NHS-esters are neutral, uncharged species. We
hypothesized that the activation of PAMAM dendrimers (con-
taining 128 terminal carboxy groups) with EDC/NHS renders it
neutral, and upon attachment to the plain NP surface its
neutrality is inherited by the negatively charged NPs, thus
lowering the stability of the resultant NP-linker colloidal
system. This could in turn lead to nanoparticle polydispersity
during antibody attachment (Fig. 1b, Step 1 and 2). However, a
second form of succinimide is available for COOH activation:
sulfo-NHS, which is known to be more water soluble and stable
against hydrolysis than NHS.19 The presence of the negatively
charged sulfonates (–SO3
) (Fig. 2, bottom) on the activated
dendrimer could maintain the necessary electrostatic repulsion
to keep the particles highly monodispersed during NP – linker
attachment (Fig. 1b, Step 1). This was a prerequisite for the
subsequent, successful protein coupling. We tested this
hypothesis using dynamic light scattering (DLS) to monitor the
particle size evolution during the reaction between NPs and the
activated dendrimers (Fig. 2A) and the succeeding protein
reaction with the dendrimer-coated NPs (Fig. 2B and C). Prior to
the addition of the activated dendrimer, the NP solutions were
monodisperse, as shown by TEM (Fig. S.1A†) and DLS
(Fig. S.4†). Upon mixing the NPs with the activated dendrimers
(using either EDC/NHS or EDC/sulfo-NHS), signicant diﬀer-
ence in particle aggregation was observed between the two
samples (Fig. 2A). Substantial clusters of NPs were detected in
the case of NHS-ester activation during the course of 30 minutes
(Fig. 2A, top). This broadening in size distribution is attributed
to the attachment of the uncharged PAMAM dendrimer and
increase in colloidal instability. This was conrmed by moni-
toring NP zeta potential. Plain NPs exhibited a zeta potential of
42.2 mV and upon binding PAMAM activated by EDC/NHS the
resultant linker-coated NP had a zeta potential of 22.5 mV
(Fig. S.1B†). In this case, this drop in zeta potential of the
colloid, oen described as ‘charge’, was insuﬃcient for retain-
ing particle stability in solution and therefore led to partial
sample aggregation (Fig. 2A, top, Scan 3). On the contrary, by
activating PAMAM with EDC/sulfo-NHS and reacting it with
NPs, the resultant NP-linker colloidal system retained its
stability (Fig. 2A, bottom). We attribute this to the fact that the
dendrimer activation strategy generates a negatively charged
macromolecule, and its physicochemical properties are inheri-
ted by the NP. This ultimately benets the NP-linker colloidal
system in terms of its overall stability and size population
distribution. Unreacted dendrimer was removed from the NP-
linker mixture and the colloids were incubated with the protein
(Fig. 2B). As a model, we have used Cy5-labeled BSA, with an
isolelectric pH of 4.7.20 The isoelectric point of the dye-doped
silica nanoparticles depends on the uorophore and it is esti-
mated between 2.0–6.3 (data not shown). Notably, the hydro-
lysis of both NHS-esters and sulfo-NHS esters is much slower atJ. Mater. Chem. B, 2015, 3, 2043–2055 | 2045
Fig. 2 Progress of protein (BSA) conjugation reactions with NPs monitored by dynamic light scattering (DLS). The evolution of the size was
measured at diﬀerent time intervals upon mixing the reagents. In the Step 1: (A) the NPs were reacted with PAMAM dendrimers activated with
either EDC/NHS (top) or EDC/sulfo-NHS (bottom). When bound to the NP surface, the negatively charged, EDC/sulfo-NHS activated dendrimer
supported NP stability in solution (unlike EDC/NHS activated PAMAM). Measured time intervals: Scan 1 – 0min, Scan 2 – 15 min and Scan 3 – 30
min; Step 2: (B) corresponds to the reaction of activated NPs with a Cy5-labeled BSA performed in MES 0.1 M pH 4.2. Measured time intervals:
Scan 1 – 0 min, Scan 2 – 60 min and Scan 3 – 120 min; and (C) size distributions of the ﬁnal Ab-NPs following the removal of non-covalently
bound protein (measured in triplicate). The use of EDC/sulfo-NHS activated dendrimer resulted in a narrow protein-coated NP size distribution.
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View Article Onlinelower pH. We have therefore chosen 0.1 M 2-(N-morpholino)
ethanesulfonic acid (MES), pH ¼ 4.2 as the optimal buﬀered
solution for the protein conjugation. Aggregation occurred
rapidly during the protein conjugation reaction with the NHS-
ester activated dendrimer-NPs (Fig. 2B, top). A very broad NP
size distribution evolved over the course of the reaction, which
carried through to the puried NP product (Fig. 2C, top).
However, the sulfo-NHS activation preserved the stability of the
colloid during conjugation (Fig. 2B and C, bottom). We attribute
this to the state of the linker-coated NPs before being reacted
with the protein. Importantly, the diﬀerences in the colloidal
stability of the samples were visible to the naked eye aer only
12 hours at 4 C (Fig. S.1D†). The monodisperse sulfo-NHS
activated dendrimer-NPs were 40% more eﬃcient in the
coupling reaction with proteins compared to that of its neutral
analogue, as determined by uorescence measurements
(Fig. S.1C†). Such increased binding eﬃciency is presumably
due to the charged nature of the overall linker-coated NPs when
reacted with proteins. By incorporating the anionic character of
the EDC/sulfo-NHS activated PAMAM dendrimers, the linker-
coated NPs displayed a zeta potential of 33.5 mV (Fig. 3) and
were therefore highly electrostatically attractive for the posi-
tively charged BSA molecules (at pH 4.2). Due to the high
probability of BSA being proximal to the linker-coated NPs in
solution, there was therefore an increased likelihood of covalent
bond formation to generate Ab-NPs. It is also important to note
that the use sulfo-NHS-ester activated NPs in this bio-
conjugation reaction with proteins allowed for the formation of
Ab-NPs of narrow size distribution. For example, in2046 | J. Mater. Chem. B, 2015, 3, 2043–2055nanomedicine, it is important to develop nanomaterials within
a given size range (typically <200 nm) such that they can avoid
clearance by the reticuloendothelial system, reduce toxicity and
successfully locate their target site of interest via the EPR
eﬀect.11 In our case, this strategy generated Ab-NPs with an
average size of 135  11 nm in diameter (Fig. 3).Conjugation of anti-CRP, a single chain variable fragment
(scFv): a demonstration of ‘active surface area’ of NPs
To demonstrate the robustness of the sulfo-NHS conjugation
strategy and to qualitatively assess that the protein on the NP
surface is in fact immobilized in its active, native form, we
conjugated small antibody fragments to NPs and show their
retained function in a simple aggregation-induced experiment
(Fig. S.2A†). These fragments, usually just the active domains of
the full proteins, are of <30 kDa in size (Fig. 1a) and can suﬀer
from relatively fast aggregation and denaturation.21 Stripped of
the glycosylated and other heavy parts of the typical full size
antibody, the fragments tend to be immobilized onto surfaces
in conformations that compromise their ability to specically
recognize their corresponding antigens. We speculate that the
3-dimensional shape, size and the exibility of the G4.5 PAMAM
dendrimer introduces a small degree of roughness on the NP
surface. As a result, the antibody fragments are ‘anchored’ on
the surface through fewer points, thus are able to retain their
specic activity and binding capacity. In our experiment, the
dendrimer-activated NPs (via sulfo-NHS-ester) were incubated
with anti-CRP scFv to produce anti-CRP coated NPs. TheThis journal is © The Royal Society of Chemistry 2015
Fig. 3 DLS data showing the size and zeta potential evolution of anti-
IgG coated NPs prepared using diﬀerent multivalent linkers. The
addition of linker molecules and antibodies to the NP surface induced
an increase in particle size. PAMAM and dextran attachment induced
NP stability and particle size increases upon linker and antibody
attachment were seen. Zeta potential analysis of the NPs showed that
PAMAM retained a high negative charge on the NP surface, whilst
uncharged dextran produced a more ‘neutral’ colloid. The attachment
of BSA led to undesirable ‘growth’ in particle size, attributed initially to
the use of glutaraldehyde.
Table 1 Coverage of NPs with antibodies
Paper Journal of Materials Chemistry B
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View Article Onlinecolloidal stability of such antibody-conjugated NPs, and their
antigen-reactivity were observed by DLS. Fig. S.2B-le† shows
that the anti-CRP-NPs were stable over the course of 3 hours of
the experiment in the absence of the penta-valent CRP-antigen,
although later measurement conrmed stability over several
months. The ‘active surface area’ of the NPs (surface of the NPs
covered by active anti-CRP) was qualitatively tested by
measuring the evolution of particle size over time aer addition
of the CRP. Upon addition of the CRP-antigen, aggregation of
the particles was induced (Fig. S.2B-right†). The resulting, time-
evolving cluster size distribution increased exponentially with
time (not shown), as expected for reaction-limited aggregation.
To support this interpretation, the anti-CRP-NP sample showed
negligible aggregation when random, non-specic protein,
human chorionic gonadotropin (hCG) was added into the
sample instead of CRP (Fig. S.2C†).Linkers Number of Ab's per NP NP coverage by Ab's
PAMAM 120  9 60  5%
Dextran 47  14 24  7%
BSA 78  6 39  3%Alternative multivalent crosslinkers: dextran and BSA
Despite the robustness of G4.5 PAMAM dendrimer in bio-
conjugation reactions, the cost of this well-dened macromol-
ecule is considerable. Therefore, we searched for alternativeThis journal is © The Royal Society of Chemistry 2015hyperbranched molecules that are readily available and inex-
pensive, but with reasonably predictable chemistries. Dextran
and BSA were chosen as appropriate models. Dextran is a
polysaccharide already used inmedicine, with well-documented
chemistry. It is neutral, water-soluble and possesses some
favorable properties such as biocompatibility and biodegrad-
ability. The use of 40 kDa dextran molecules to attach anti-
bodies onto a at surface of biosensor devices has been well
described in the literature.22–24 Jonsson et al. presented an
interesting approach to gra antibodies onto plastic substrates
using dextran ‘activated’ by oxidation using NaIO4.25 We have
adapted this method for the silica NPs. Oxidation of dextran
using NaIO4 generates polyaldehyde dextran that can then act
as a crosslinker with the primary amines of the NPs, and those
of proteins, via Schiﬀ base formation. The detailed optimization
of this reaction including the eﬀects of reaction variables on the
reaction eﬃciency and colloidal stability of the NPs are
summarized in the ESI.† BSA and other albumins are also
widely studied supramolecules and are the most abundant
proteins in plasma.26,27 Albumins are characterized by high
content of charged amino acids, aspartic and glutamic acids,
lysine, and arginine.28 Activation of the surface carboxylic acids
with EDC/sulfo-NHS leads to rapid gelation of a BSA solution
(not shown). Alternatively, additional steps employing glutar-
aldehyde were introduced to obtain the BSA-coated NPs, onto
which antibodies could be immobilized. To compare the bio-
conjugation eﬃciency of the various multivalent linkers and the
eﬀect of the reaction conditions, we have graed full size anti-
bodies (Alexa Fluor 647 goat anti-human IgG) onto the surface
of silica NPs as illustrated in Scheme 1. The number of anti-
bodies immobilized on the NPs was quantied by using uo-
rescence measurements and described in Table 1. The eﬀect of
the surface chemistries on the NP charge and size was evaluated
by DLS and shown in Fig. 3 and S.4.†
The incremental increase in the size of the NPs using the
PAMAM and dextran method corresponded well to the size of
the material that was being immobilized in each reaction step.
PAMAM and dextran both have individual sizes of approxi-
mately 4–5 nm. The changes in the zeta potential (as an indi-
cator of charge) of the NPs were as expected for both PAMAM
and dextran-coated NPs. The zeta potential of the dextran-
coated NPs changed to 22.5 mV, which conrmed that such
neutral hyperbranched glucan was rmly immobilized on the
NP surface. The value rose to 32.5 V aer the reaction with
antibodies, indicative of successful conjugation. Though the
dextran-coated NPs exhibited a zeta potential similar to that of
PAMAM-coated NPs activated by EDC/NHS, dextran acts as aJ. Mater. Chem. B, 2015, 3, 2043–2055 | 2047
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View Article Onlinesteric barrier to the aggregation of adjacent NPs and they ulti-
mately remain stable in solution during the bioconjugation
reaction. Importantly for both PAMAM and dextran, no visible
or measurable aggregation of the NPs was detected during any
of these steps. On the other hand, the BSA procedure showed
signs of a small degree of aggregation. The original size of the
plain NPs was 106 nm; the BSA-coated NPs ‘grew’ to 186 nm
and the size of the nal Ab-NPs for the BSA method reached
nearly 228 nm. This undesired eﬀect was attributed to the
introduction of the additional steps, in which glutaraldehyde
(monovalent, homo-functional crosslinker) was employed to
produce the BSA-coated NP intermediate. We have reported
previously on the negative eﬀect of monovalent linkers in bio-
conjugation reactions.18 To this end, all three methods yielded
in Ab-NPs with diﬀerent surface coverage of antibodies
(Table 1).
The robust and reliable conditions for the PAMAM den-
drimer reaction resulted in the highest yield of antibodies per
NP. The yield for the reaction using multivalent dextran, on the
other hand, was the lowest. This is presumably because
PAMAM-coated NPs are more negatively charged than dextran-
coated NPs, thus the former NPs electrostatically attract more
antibodies in solution (which in turn leads to higher probability
of covalent bond formation). This is in agreement with our
previously published data on the use of diﬀerent generations of
PAMAM dendrimer (antibody-coated surface area of NPs
decreases with decreasing generation of PAMAM dendrimer16).
On the whole, PAMAM and dextran crosslinking strategies
appear to be very robust in that they generate stable, mono-
disperse Ab-NPs. Although the BSA method bound a relatively
high number of antibodies per NP (78 per NP), the fact that the
overall NP size was in excess of 200 nm suggests that this
method of graing antibodies to NPs results in a small degree of
NP aggregation. However, high antibody surface-coverage does
not necessarily equate to high antibody activity. In the last
section of this manuscript, the performance of Ab-NPs prepared
by these methods will be evaluated in a simple uorescence-
linked immunoassay.Evaluation of NP stability upon storage and long distance
transportation through interactions studies with in vitro cell
cultures
Nanomaterials are usually prepared by expert material scien-
tists who oen rely on biologists and clinicians to apply such
prepared materials in many in vitro and/or in vivo experiments.
It is therefore imperative to control the conditions of the
nanoparticle storage so that the samples retain their unique
properties and function over a long period of time. Crucially,
the storage method should also enable simple means of trans-
portation of the nanomaterial. The most convenient methods to
preserve the nanomaterial and extend its shelf-life include
storing the samples in solution at either +4 C or 20 C or in a
dried state by a method known as lyophilisation (or freeze-
drying). Lyophilisation might be the preferred method because
it reduces the cost and simplies long distance transportation.
However, the freeze-drying process can add extensive strain on2048 | J. Mater. Chem. B, 2015, 3, 2043–2055the nanomaterial, which oen leads to particle aggregation.
This phenomenon is particularly notable with antibody-coated
nanoparticles. Before lyophilisation, it is therefore a common
practice to suspend the NPs in formulations containing ‘cryo-
protectants’, which are typically glycols or sugar-containing
solutions. Common examples of the dessication-stress protec-
tants that are widely used in the industry are trehalose, glucose,
sucrose, fructose, dextran, mannitol and sorbitol.29 The choice
of the cryoprotectant will signicantly inuence the nano-
particle aggregation, which in turn presents important conse-
quences on the interactions between the NPs and a biological
material, such as cells. In the initial experiment, we have
qualitatively investigated the eﬀects of trehalose (2% (w/v)), a
commonly used cryoprotectant, on the colloidal stability of
silica NPs (plain FITC-doped and human IgG-coated) and their
interactions with HeLa cells.
The results obtained using CLSM and SEM, shown on Fig. 4,
provided very important information. Firstly, the optical prop-
erties of NPs were not aﬀected by the storage procedure and due
to their green uorescence emission they were clearly visible
under a CLSM (Fig. 4a). NPs can be observed either internalized
in the cytoplasm or associated to the cell surface (arrows in
Fig. 4a). Secondly, upon reconstitution in the cell culture
medium and 60 minutes incubation with the cells, the IgG-
coated NPs were observed to form aggregates at the micrometer
scale and adhered to the surface of the cell (Fig. 4b and a
magnied area containing NP aggregates is shown in Fig. 4c).
Presumably, such large NP clusters were formed as a result of
structural changes of the NP-bound proteins during the freeze-
drying process, during the subsequent sample-reconstitution
method, imbalanced charge eﬀects of the Ab-NPs in the high-
salt concentration aqueous medium or a combination of these
eﬀects. By contrast, the unmodied NPs, freeze-dried from the
same solution, appeared monodisperse. Due to their small size
(100 nm), they were unable to be seen (Fig. 4d) at the same
magnication, at which Ab-NP aggregates were observed.
Moreover, these NPs were homogenously distributed and
adhered over the cell surface (Fig. 4e). These simple, qualitative
experiments critically highlighted the need for a simple
screening protocol that would allow for the identication of the
most reliable cryoprotectant and storage conditions, especially
for protein coated-NPs. Without a storage method that does not
inuence the Ab-NP performance, it is unrealistic to envisage a
successful translation of such nanomaterials into a biological
setting.The eﬀect of cryoprotectants on the long-term storage and
manipulation of Ab-NPs
In light of the cellular uptake experiments, we considered it
absolutely necessary to prepare the Ab-NPs under conditions
that allowed for long-term storage without any damage to the
expensive antibodies on the NP surface. Equally important, the
storage method must enable cost-eﬀective transport of the
nanomaterial and easy reconstitution of the Ab-NPs in the
desired medium. The specic condition for the latter is that the
end-user should be able to re-dissolve the Ab-NPs withoutThis journal is © The Royal Society of Chemistry 2015
Fig. 4 HeLa cells interacting with NPs (plain and human IgG-coated,
freeze-dried in 2% trehalose solution). (a) After storage and shipment,
NPs do not lose their optical properties (green ﬂuorescence) and are
clearly visible under CLSM. Cells were further stained to make their
membranes (red) and nuclei (blue) visible. NPs are observed either
internalized or interacting at the cell surface level (arrows). (b)
Following reconstitution in MEM and incubation of IgG-coated NPs
with the cells, micron sized colloidal aggregates were visualised by
SEM. (c) A 5000 magniﬁed image of (b). (d) In contrast, plain NPs
remained monodisperse (100 nm) and were homogenously distrib-
uted over the cell surface (e).
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View Article Onlineexcessive manipulation with the sample (e.g. ultrasonication,
vortexing etc.).
In an ideal scenario, a solid formulation of the Ab-NP sample
should be reconstituted in the desired solvent by simply
shaking it by hand. Such reformed Ab-NP solution should
maintain excellent colloidal stability for the minimum of 2
hours, which was arbitrarily chosen as a suﬃciently long
working-window for the end-user to manipulate with the NPs
(i.e. for sample dilution, partition, sterilization, etc.). We believe
this to be a frequently overlooked facet of nanomaterial prep-
aration and it is in fact of paramount importance. Addressing
these storage issues means scientists could then condently
know that the re-dispersed material is as close to identical as its
pre-storage form as possible.
Several useful articles review the freeze-drying process.17,30,31
This simple method is based on removing water from a frozen
sample by sublimation and desorption under vacuum. It isThis journal is © The Royal Society of Chemistry 2015argued though that this process generates various stresses
during freezing and drying steps. Therefore, cryoprotectants are
usually added to the formulation to protect the nanoparticles
from freezing and desiccation stresses. The most popular
cryoprotectants encountered in the literature for freeze-drying
nanoparticles are sugars: trehalose, sucrose, glucose and
mannitol.17 In the cell-interaction experiment, trehalose was
identied as an ineﬃcient protectant for the Ab-NPs system. We
have therefore investigated the eﬀect of another common
stabilizer – sucrose and one unusual protectant – BSA on the
colloidal stability of the reconstituted NPs and Ab-NPs. The
experimental design is illustrated on Fig. S.5.† Initially,
considering the protocols published by industrial laboratories,
plain NPs were freeze-dried in solutions containing either
sucrose (20% w/v) or mixtures of BSA and sucrose (1–6% w/v
BSA + 20% w/v sucrose). The samples were freeze-dried and
stored for several days before they were reconstituted in
0.01 M PBS solution and also in a commonly used cell
culture medium called Minimum Essential Medium (MEM).
MEM is an enriched basal medium that enhances growth of
sensitive or diﬃcult to culture mammalian cells. The only
user manipulation involved the addition of the desired
medium to the solid-form nanoparticles and shaking the
nanoparticles into solution by hand (see Movie† at: https://
www.youtube.com/watch?v¼HczrDJCaC38). The size of the
NPs upon re-dispersion was measured by DLS, as was the
evolution of the NP size over the course of 4 hours. The results,
summarized in Fig. 5 show that the addition of 20% w/v of
sucrose had a destabilizing eﬀect on the colloid in both PBS
and MEM. However, the addition of BSA had a stabilizing
inuence in both media (Fig. 5A le & centre, S5A and S5B†).
When BSA (1–6% w/v) was solely used as the cryoprotectant the
colloid reconstituted in MEM retained its excellent stability for a
minimum of 2 hours (Fig. 5A right). 1% w/v BSA solution was
identied as the optimal concentration to protect the solid
formulation of the NPs. Addition of the MEM medium to the NP
pellet containing 1% w/v BSA stabilized the NP solution for 4
hours (Fig. 5A right). In addition, a similar experiment was per-
formed upon re-dissolving the NP pellet in Dulbecco's Modied
Eagle's Medium (DMEM). DMEM is an example of an even more
complex cell culture medium that contains approximately four
timesmore vitamins and amino acids and two to four timesmore
glucose than the MEM formula used. As seen in Fig. S.6B,† the
NP pellet containing 1% w/v BSA retained excellent colloidal
stability upon re-dispersion for up to 2.5 hours. However, in order
to demonstrate the real practicality of the freeze-drying approach
employing cryoprotectants, we examined the colloidal stability of
antibody-coated NPs. Firstly, goat anti-human IgG was conju-
gated to the NPs using the three multivalent-linkers strategies
described in this study. All prepared Ab-NP samples were tested
by DLS and showed well-dened sizes (Fig. 3) before they were
lyophilized from a solution containing 0, 1, 3 and 6% w/v BSA.
Aer several days of storage, they were reconstituted both in
water and PBS. PBS usually has a destabilizing eﬀect on Ab-NPs
colloidal stability due to the high content of NaCl (0.137 M), and
also it is a good example of an isotonic medium widely used both
in immunodiagnostics and nanomedicine applications. Fig. 5BJ. Mater. Chem. B, 2015, 3, 2043–2055 | 2049
Fig. 5 Nanoparticles were freeze-dried from solutions containing various cryoprotectants (described in legends) and redispersed in DI water,
PBS or MEM. Redispersion was performed by adding the appropriate medium to the solid form NPs and shaking the dried samples (by hand) back
into solution (A) unmodiﬁed NPs were freeze-dried in diﬀerent concentrations of BSA (right) or BSA solutions containing 20% sucrose (left and
centre). The solid form of unmodiﬁed NPs was reconstituted in PBS and MEM; (B) with BSA clearly demonstrating a stabilising eﬀect during
freeze-drying, Ab-NPs prepared with diﬀerent linkers were redispersed in water and PBS after being freeze-dried in a 0% (i.e. only DI water), 1%,
3% or 6% BSA solution. Following redispersion, the evolution of particle size over time was monitored by DLS.
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View Article Onlineillustrates that yet again, 1% w/v BSA concentration as the cryo-
protectant has a stabilizing eﬀect on the Ab-NP solution in both
water and PBS. In the absence of the stabilizers (i.e. freeze dried
in DI water), it was not possible to re-dissolve the Ab-NPs in
aqueous solvent by shaking it by hand without a high degree of
aggregation (0% w/v BSA). Such samples would be practically
unusable without ultrasonication. Overall, we demonstrated
that it is possible to precisely control the freeze-drying of
colloidal systems in order to reach a long shelf-life of the Ab-NPs
and to empower the end-user to exploit the full potential of the
nanomaterial without unnecessary manipulation of the samples
that could potentially damage proteins bound to the surface of
the NPs.The function of Ab-NPs measured by immunoassay
High surface coverage of antibodies in Ab-NPs does not auto-
matically translate to better performance of the Ab-NPs in2050 | J. Mater. Chem. B, 2015, 3, 2043–2055applications such as biomedical sensing and drug delivery.
Specic to these practices, one critical parameter that measures
the function of the Ab-NPs is their signal-to-noise ratio (S/N). In
diagnostics, this relates to the ‘positive’ signal generated by the
specic Ab-NPs/antigen binding compared to the signal
obtained in the absence of the antigen (i.e. non-specic
binding). For targeted drug delivery and in vivo imaging, the S/N
denotes the selective binding of the nanocarrier (e.g. Ab-NPs) to
the desired cells/tissues with minimal collateral exposure to
other cells. The function of the Ab-NPs prepared by the methods
presented in this article was evaluated in a simple uorescence-
linked immunoassay. The schematic of the assay format is
illustrated on Fig. S.7.† All Ab-NPs were freeze-dried from a
solution containing 1% w/v BSA as the cryoprotectant. The S/N
value for Ab-NPs is underpinned by the ‘active surface area’
(ASA), i.e. surface area of NPs covered by antibodies in their
active, native state, available to bind to their target. We
hypothesized that the higher the ASA, the higher is the S/N. TheThis journal is © The Royal Society of Chemistry 2015
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View Article OnlineASA for our Ab-NPs was modulated by the diﬀerent multivalent
linkers and the underlying conjugation chemistries. However,
in nanomedicine, the ASA can also be impeded by the protein
adsorption layer (known as a “protein corona”) that forms on
the surface of colloidal nanoparticles in biological media such
as serum or plasma.32 The Dawson group has shown that this
corona eﬀect plays a key role at the nanoparticle-tissue/cell
interface. A corona of adsorbed proteins on the nanoparticle
surface is in fact what interacts with the biological machinery of
cells rather than the carefully engineered particle surfaces
created by materials scientists.33 We have therefore probed the
performance of Ab-NPs in immunoassays using PBS, 10% fetal
bovine serum (FBS) and whole FBS as reactionmedia. As before,
the solid formulations of Ab-NPs used in the immunoassays,
were re-dispersed in these media by shaking by hand. To
determine the specic vs. non-specic binding phenomenon,
goat anti-human IgG (hAb-NPs) and goat anti-rabbit IgG (rAb-
NPs) antibody-coated NPs were prepared using the three
multivalent linkers. Both hAb-NPs and rAb-NPs were incubated
in 96 well plates modied with either human IgG or BSA
respectively. Only the hAb-NPs were expected to bind to theFig. 6 Immunoassay results and the corresponding signal-to-noise (S/
when introduced to either human IgG or BSA coated surfaces. Increasing
protein corona. The high active surface area of Ab-NPs using PAMAM s
dextran were coated with less antibodies, the ability of the sugar to sup
Dextran is therefore a viable alternative multivalent linker to costly PAMA
This journal is © The Royal Society of Chemistry 2015human IgG antigen present in the wells. We have also compared
the S/N ratios of these Ab-NPs to that of free dye-labelled goat
anti-human and goat anti-rabbit IgG to gauge the reporting
capacity of the FITC-NPs versus free dye. The uorescence signal
in each well was recorded using a uorescence plate reader; the
immunoassay results are displayed in Fig. 6. The results suggest
that all of the Ab-NPs outperformed the free-antibody. Although
this is in agreement with our previous published work,18 such
results were not so easily predicted for the assays performed in
10% and whole serum. What is evident though, is that the
‘protein corona’ eﬀect has played a signicant role in the
performance of the Ab-NPs. While the specic signal (Fig. 6, red
stripy bars) was relatively high in PBS, it signicantly dropped
when the buﬀer was being replaced by FBS (red striped bars in
10% and whole serum). We presume that a corona occurs on the
Ab-NPs and therefore leads to a decrease in ‘positive’ binding.
The eﬀect of the diﬀerent media played little role for Ab-NPs
using PAMAM, which justies the use of such linkers and the
reliability of the method. Also, the PAMAM hAb-NPs showed the
highest specic signal (red stripy bars) across all tested media.
Interestingly though, the non-specic binding (grey bars) ofN) ratios for goat anti-human (hAb) and anti-rabbit (rAb)-coated NPs
serum concentration saw a decrease binding due to the presence of a
howed the best performance in whole serum. Though Ab-NPs using
press non-speciﬁc binding allowed for a S/N comparable to PAMAM.
M.
J. Mater. Chem. B, 2015, 3, 2043–2055 | 2051
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View Article OnlinePAMAM hAb-NPs was relatively high in PBS but improved when
introduced to complex serum conditions: S/N of 5.0 in PBS
compared to 5.8 and 6.1 in 10% and whole serum respectively.
The S/N ratio of the Ab-NPs in PBS decreased in the following
order: dextran > BSA > PAMAM. This was surprising nding for
the dextran method. As presented earlier in this article, the Ab-
NPs prepared by the dextran-mediated method yielded the
lowest quantity of antibodies per one NP (Table 1). However,
because of its low non-specic binding (grey bars), the dextran
hAb-NPs showed the highest S/N ratio in PBS. This outcome is
attributed to the combination of the following two parameters:
(1) high active surface area – high % of active antibodies on the
NP surface and (2) the consequences of dextran's hydration and
swelling ability, which helps to suppress non-specic binding of
molecules on its surface. The S/N ratio of dextran hAb-NPs
dropped in serum but it was still comparable to the PAMAM
nanoparticles, which is remarkable considering the diﬀerences
in cost between the two hyperbranched linkers. On average, the
BSA molecule proved to be the least eﬀective crosslinker for the
conjugation of antibodies onto the NP surface. Its S/N ratio was
the lowest in serum, which was ascribed to the issues related to
the low degree of aggregation specic to this sample. All things
considered, we have identied an inexpensive alternative to the
robust PAMAM-conjugation approach to immobilize antibodies
on the NP surface. The use of readily available dextran proved to
be straightforward with evident benets for the nanoparticle's
colloidal stability and its function.
Conclusions
It can be argued that the surface chemistry strategies presented
in this article are not universal and adaptable to every type of
known nanomaterial. In this work however, we aimed to
empower scientists with a robust and reliable ‘recipe’ or refer-
ence point for producing protein-coated nanomaterial that will
enable the translation of the “on-bench potential” towards
commercially attractive products or applications. We tried to
clarify some currently used misconceptions and formulate
some of the unaddressed challenges related to the active surface
area of antibody-coated nanoparticles and the most appropriate
means of preserving and handling them. We have investigated
the optimal conditions for bioconjugation strategies to immo-
bilize three diﬀerent proteins on the surface of silica nano-
particles. We have probed the function of the protein-coated
nanoparticles using mainly two analytical tools, usually readily
available to material scientists: DLS and uorescence spectro-
photometry. We have shown that the physicochemical proper-
ties of the chosen crosslinker play a fundamental role in
nanoparticle colloidal stability and antibody binding. In
particular, we have shown that when activated using EDC/sulfo-
NHS that the PAMAM mediated immobilization method is very
robust and reliable for both full size antibodies and also their
single chain variable fragments. Signicantly though, the
dextran method represents a very good and cost eﬀective
alternative to PAMAM. It is quite clear that to translate the many
formulations of nanomaterials, such as drug delivery systems or
signal reporters into the clinical market, expertise from a2052 | J. Mater. Chem. B, 2015, 3, 2043–2055multitude of disciplines including chemistry, materials science,
engineering, biology, pharmaceutical sciences, and clinical
research is required. Therefore, we have crucially established
the most adequate protocols for storage and reconstitution of
the nanomaterial with minimum end-user manipulation. To
this end, freeze-drying as the optimal method and BSA (1% w/v)
as the optimal example of cryoprotectant were identied to
preserve the colloidal stability of our Ab-NPs in biologically
relevant media. However, a number of challenges remain before
such nanomaterials can be produced industrially; for example,
would the conjugation reactions be as eﬃcient if performed on
a larger scale? We believe that the work presented in this article
will help to advance the multidisciplinary eﬀorts for the
common objective of clinical benets of nanotechnology.Experimental
Materials
Cyclohexane (anhydrous, 99.5%), 1-hexanol (anhydrous,
$99%), Triton® X-100, aminopropyl trimethoxysilane [APTMS]
(97%), tetraethyl orthosilicate [TEOS] (99.99%), ammonium
hydroxide solution (28% w/v in water, $99.99%), 3-(trihydroxy-
silyl)propyl methylphosphonate monosodium salt (42 w/v in
water) [THPMP], poly(amidoamine) [PAMAM] dendrimer
(ethylenediamine core, generation 4.5 solution, 5% w/v in
methanol), albumin from bovine serum (lyophilised powder,
$98%), glutaraldehyde (50% w/v in water), sucrose (for micro-
biology,$99.0%), 6-aminohexanoic acid ($98.5%), dextran (from
Leuconostoc spp,Mr 40 000), sodium periodate (99.8%), sodium
borohydride ($99%), N,N-dimethylformamide (anhydrous,
99.8%) [DMF], IgG from human serum (reagent grade,$95%), 4-
morpholoneethanesulfonic acid [MES] ($99%), Tween®20,
trehalose dehydrate ($99.0%), fetal bovine serum, N-hydroxy-
succinimide (98%), fetal bovine serum and Dulbecco's Modied
Eagle Medium – high glucose were purchased from Sigma
Aldrich. Absolute ethanol, 1-ethyl-3(3-dimethylaminopropyl) car-
bodiimide HCl [EDC], phosphate buﬀer saline tablets (one tablet
dissolved in 200 mL DI water yields 0.01 M phosphate buﬀer, pH
7.4) were purchased from Fisher Scientic. Here aer, the use of
‘PBS’ refers to 0.01 M PBS, pH 7.4. N-Hydroxysulfosuccinimide
sodium salt (>98%) was purchased from TCI. AlexaFluor®647
labelled goat anti-human and goat anti-rabbit IgG (H + L, 2
mgmL1), minimum essential mediumwere purchased from Life
Technologies. Transparent Nunc Maxisorb 96 well plates used in
the immunoassay were purchased from Fisher Scientic. Deion-
ised water (<18 MU) was obtained from a Milli-Q system from
Millipore. The dye used in this work, uorescein isothiocyanate
isomer (95%) was purchased from ABCR.Synthetic procedures
General procedure for the synthesis of nanoparticles. The
dye-doped silica nanoparticles were synthesised using a
quaternary reverse microemulsion method.34 Briey, FITC dye
(2.5 mg) and APTMS (5.6 mL) were conjugated with stirring in a
dried glass vial containing 2 mL of 1-hexanol for 2 h. Aer 2 h,
cyclohexane (7.5 mL), 1-hexanol (1.133 mL), Triton® X-100This journal is © The Royal Society of Chemistry 2015
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View Article Online(1.894 g), DI water (0.48 mL), dye conjugate solution (0.666 mL)
were added to a 30 mL plastic bottle under constant stirring.
100 mL TEOS was then added. Aer 30 min, 40 mL of ammonium
hydroxide solution was added to catalyse the nanoparticle
synthesis reaction and was le to stir for 24 h. Subsequently,
TEOS (50 mL) was added to the reaction mixture. Aer 30 min,
THPMP (40 mL) was added and, 5 min later, APTMS (10 mL) was
introduced. The solution was stirred for a further 24 h. The
microemulsion was broken through the addition of 30 mL
ethanol. The nanoparticles were then puried by centrifugation
in ethanol (14 000 rpm, 7 min,3). The centrifugation steps led
to the formation of a NP pellet. The supernatant was removed
and the pellet was re-suspended in fresh ethanol, ultrasonicated
and then re-centrifuged. Aer purication the nanoparticles
were stored in ethanol solution at 4 C.
Conjugation of proteins to NPs using G4.5 PAMAM den-
drimer. 1 mmol (526 mL) of PAMAM dendrimer was used to
dissolve 73.6 mg EDC. This solution was then added to 42.6 mg
of sulfo-NHS or 23.0 mg NHS. 16 mL of 1 N HCl was added to the
solution, and was topped up to 1mL using DI water. The sample
was allowed to shake for 20–25 min at 600 rpm using Stuart SA8
vortex mixer. The activated dendrimer solution was then added
to 2 mg of NP pellet. The NPs were redispersed into the den-
drimer solution via ultrasonication. The sample was shaken for
15 min. Aer 15 min the sample was centrifuged (14 000 rpm, 8
min). The supernatant contained unbound dendrimer and was
discarded. The pellet contained dendrimer-coated NPs and was
redispersed (via ultrasonication) in 968.5 mL MES buﬀer (pH
4.2, 0.1 M). 31.5 mL of 2 mg mL1 AlexaFluor647 goat anti-
human or goat anti-rabbit was added to the dendrimer-coated
NP solution and allowed to shake for 4 hours at 600 rpm. Goat
anti-human and anti-rabbit IgG contained 4 moles of dye per
antibody. The concentration of protein added was calculated
using Bangs Lab Technical Note 205. The amount of proteins
needed to achieve high nanoparticle surface coverage was
determined from the formula:
S ¼

6
rsd

C
where S ¼ amount of protein required to achieve surface satu-
ration (mg protein per g nanoparticle), rs is solid sphere density
(2.4 g cm3 for silica), d is the mean particle diameter (which,
from TEM, was calculated to be 80 nm) and C is the capacity of
sphere surface for a given protein (mg protein per m2 of sphere
surface), which is approximately 2.5 mg m2 for IgG molecules
and 3 mg m2 for BSA. For purication, the sample was
centrifuged for 8 min at 14 000 rpm, sonicated and redissolved
in 1 mL PBS (4).
Conjugation of proteins to NPs using dextran. 500 mL of 40
mM of sodium periodate (in DI water) was added to 1 mmol 40
kDa dextran in a 2 mL centrifuge tube and shaken at 600 rpm
for 1.5 h. The dextran solution was then added to 1 mg of NP
pellet, ultrasonicated and shaken for 1 h. 500 mL of 40 mM of
sodium borohydride (in DMF) was added directly into the NP–
dextran solution, which was then shaken for 25 min. The
sample was then centrifuged (14 000 rpm, 8 min, 2). The NP
pellet was dispersed (via ultrasonication) in DI water aer theThis journal is © The Royal Society of Chemistry 2015rst centrifugation. This procedure was shown to be most
eﬀective way of conjugating dextran to the NP surface (Fig. S.3†).
Aer the second centrifugation, the pellet was redissolved in
500 mL of 40 mM of sodium periodate and shaken for 30 min
(600 rpm), and then centrifuged (14 000 rpm, 8 min, 2). Aer
the second centrifugation, 484 mL 0.1 M MES pH 4.2 was added
to the pellet and sonicated. 16 mL of AlexaFluor647 antibody was
added and shaken for 4 h (600 rpm). 500 mL of 40 mM sodium
borohydride (in DMF) was added directly into the tube and
allowed shake for another 40 min. The sample was puried as
per the PAMAM section.
Conjugation of proteins to NPs using BSA. 1 mL of 10% (w/v)
glutaraldehyde in PBS was added to 2 mg of NP pellet. The
sample was ultrasonicated and shaken for 45 min at 800 rpm.
The sample was centrifuged and pellet was resuspended in 900
mL PBS, followed by the addition of 100 mL BSA solution (30 mg
mL1). The sample was allowed to shake for 2 h at 800 rpm. The
sample was centrifuged (14 000 rpm, 5 min) and the pellet was
redispersed in 1 mL 10% glutaraldehyde in 0.01 M PBS pH 7.4
and allowed to shake for 75 min (800 rpm). The sample was
centrifuged (14 000 rpm, 5 min) and the pellet was redispersed
in 968 mL 0.01M PBS, pH 7.4. 32 mL of AlexaFluor647 antibody (2
mgmL1) was added to the sample and allowed to shake for 2 h.
Aer 2 h, the sample was centrifuged (14 000 rpm, 5 min) and
the pellet was redispersed in 1 mL of 1% BSA, 40 mM amino-
hexanoic acid in 0.01 M PBS pH 7.4 for 15 min. The sample was
puried as per the PAMAM section.
Freeze-drying
NP samples (plain or protein-coated) were suspended in DI
water such that their concentration was 2mgmL1 100 mL of NP
sample was added to 100 mL of particular cryoprotectant solu-
tion. The aliquots were then frozen using liquid nitrogen and
lyophilised. For example, 100 mL of NPs was added to 100 mL of
2% (w/v) BSA solution (i.e. each aliquot contained 200 mg of NPs
in a 1% BSA solution). The aliquots were then frozen using
liquid nitrogen and lyophilised using a ScanVac Coolsafe freeze
drier connected to an Edwards RV12 pump. Following freeze
drying, the various solid form NPs were stored at 20 C until
further use.
Nanoparticles characterization
Transmission electron microscopy. TEM micrographs were
obtained using a Joel JEM-3200FS transmission electron
microscope operated at 150 kV. Sample preparation involved
carefully pipetting ethanol solutions (2 mL) of NP onto ‘Carbon
Films on 400 Mesh Grids Copper’ from Agar Scientic.
Dynamic light scattering. DLS experiments were performed
using a Malvern Zetasizer. Nanoparticle size and zeta potential
were used for analyzing the evolution of the nanoparticles aer
the various surface treatments. Particles were dispersed in DI
water during analysis and measurements were taken at 25 C.
All NP dispersions were analyzed at a nanoparticle concentra-
tion of 1 mg mL1 in water. The stability of the dispersions was
monitored at 25 C over a period of 4 hours with the average of
30 measurements taken at two minute intervals. AllJ. Mater. Chem. B, 2015, 3, 2043–2055 | 2053
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View Article Onlinemeasurements were performed in triplicate with two diﬀerent
batches of sensitized Ab-NPs. Nanoparticles (either plain NPs or
Ab-NPs) were freeze dried in various cyroprotectant media. 1 mL
of an appropropriate medium (water, PBS, MEM or DMEM) was
added to a sample, the sample was shaken by hand and gently
mixed with a pipette (see Movie at https://www.youtube.com/
watch?v1/4HczrDJCaC38†) to redisperse. The sample was then
added to the Zetasizer and size analysis was performed at 25 C
every 30 minutes for 4 hours, with an average of 30 measure-
ments per time interval. For the antigen-mediated NP aggre-
gation studies, 1 mL of CRP solution (at a concentration of 2.42
mg mL1 in PBS 0.01 M, pH 7.4) was introduced to the nano-
particle dispersion (1 mL DI water). The DLS measurement was
immediately started without further perturbation of the
dispersion.
Fluorescence analysis. For quantifying the number of
antibodies per nanoparticle, standard 96 well plates Nunc
Maxisorb 96 well plate were performed on a Tecan Innite
M200 Pro Sare microplate reader. Calibration curves for
FITC-doped nanoparticles and AlexaFluor647 goat anti-
human/-rabbit IgG were constructed in order to calculate the
number of antibodies per nanoparticle. In order to account for
dye-leeching from the NP core, the calibration curve for FITC-
doped nanoparticles used nanoparticles that had undergone
the same reaction conditions as those during the bio-
conjugation reactions. For FITC nanoparticles, excitation and
emission wavelengths used were 490 nm and 525 nm respec-
tively. For AlexaFluor647 antibody readings, excitation and
emission wavelengths were 647 nm and 677 nm respectively.
Gain settings of 75 and 110 were used for FITC and Alexa-
Fluor647 respectively.
Direct binding assay. Using Nunc Maxisorb 96 well plates, 60
mL of 50 mg mL1 human IgG and 1% BSA (both in 0.01 M PBS
pH 7.4) were added to respective wells and le overnight at 4 C.
Human IgG wells served as a positive/negative control for goat
anti human/rabbit IgG coated NPs. BSA was used as it exhibits
low non-specic binding, thus serving as a background refer-
ence since low number of Ab-NPs would bind to this surface.
The plate was then cleaned by washing the wells with 120 mL
0.2% (v/v) Tween in PBS and then PBS (2). All wells were then
blocked with 120 mL of 1% (w/v) BSA solution in PBS and
incubated at 37 C for 2 h. The same well cleaning procedure
was used as before. Solid form Ab-NPs (goat anti-human or anti-
rabbit IgG coated nanoparticles, freeze-dried in 1% BSA) were
re-dispersed in either 0.01 M PBS pH 7.4, 10% FBS in PBS or
whole FBS such that their concentration was 0.4mgmL1. 70 mL
of Ab-NP sample was added to both types of well (human IgG
coated and BSA coated). 70 mL of free AlexaFluor647-labelled
goat anti-human and goat anti-rabbit IgG was equal to the
number Ab-NPs introduced per well. The plate was then incu-
bated overnight at 4 C. The wells were cleaned as before and
dried with a stream of nitrogen. 60 mL of PBS was added to the
wells and uorescence readings for FITC-doped NPs and free
antibody (AlexaFluor®647) were carried to investigate their
respective signal-to-noise ratios.2054 | J. Mater. Chem. B, 2015, 3, 2043–2055Cell cultures
Cell culture maintenance. Human Epithelial Cervical
Adenocarcinoma Cells (HeLa, ATCC) were cultured in 1
Minimal Essential Medium (MEM, Gibco by Life Technologies)
supplemented with 10% w/v fetal bovine serum (FBS, Biowest)
and 2 mM L-glutamine (L-Glut, Life Technologies), subsequently
referred to as supplemented MEM. Cell culture maintenance
was done in T25 or T75 asks (Thermo Scientic) and cultures
were kept in an incubator (Hera Cell 150, Heraeus) at standard
conditions (37 C and humidied atmosphere of 5% CO2)
during incubation and post-incubation times.
Cell culture for specic analysis. To carry out analysis
through Scanning Electron Microscopy (SEM), round glass
coverslips (Knittel Glass) were placed into 4 well plates (Nunc,
Thermo Scientic) in order to make cells grow on the coverslips.
To perform Confocal Laser Scanning (CLSM) studies, cells were
directly cultured in 35 mm diameter glass bottom Petri dishes
(MatTek Corporation). In both cases, a solution containing
supplemented MEM with 1.5  104 cells was added in each well
or Petri dish and then cultures were placed in an incubator at
standard conditions. Assays were carried out aer complete cell
adhesion and once cultures had reached exponential growth,
normally one day following cell seeding.
Study of the interactions of NPs with HeLa cells and analysis
by CLSM. Plain, modied NPs and human IgG-coated NPs were
freeze-dried in 100 mL aliquots (2 mg mL1) in a 2% (w/v)
trehalose solution. The IgG-coated NP were prepared similarly
to the AlexaFluor 647-labelled anti-human/rabbit IgG coated
NPs described in the ‘Conjugation of proteins to NPs using G4.5
PAMAM dendrimer’ methodology. A 50 mg mL1 solution of
silica NPs prepared in supplemented MEM (1 mL nal volume)
was added into each Petri dish and incubated for 60 min. Aer
incubation, NP solution was removed from each Petri dish and
1 mL of fresh supplemented MEM was added. To check the
interaction of the NPs (green uorescence emission) with cells,
they were labelled with CellMask™ Deep Red plasma
membrane Stain (Life Technologies, far-red uorescence emis-
sion) to set the cell limits and Hoechst to stain the nucleus (Life
Technologies, blue uorescence emission). Images in random
areas of the cultures were acquired with a Leica SP5 Confocal
Laser Scanning Microscope and interaction of NPs with cell
cultures was analyzed by means of localization within the cells.
Study of the interactions of NPs with HeLa cells and analysis
by SEM. A 50 mg mL1 solution of silica NPs prepared in sup-
plemented MEM was added into each well and let incubate for
60 min. Aer incubation, the NP solution was removed from
each well and 0.1 M cacodylate buﬀer (TAAB) was added. Aer 2
min, TAAB was removed and 2.5% glutaraldehyde (Merck) was
added and incubated for 45 min in order to carry out the xa-
tion of the cells. The xative was removed and cells were
dehydrated through series of increasingly graded ethanol
(Merck Millipore), in which each step (50%, 70% and 90% once,
and 100% twice) lasted 8 min. Finally, cells were incubated with
hexamethyldisilazane (Electron Microscopy Sciences) to
completely dry the samples. Finally, coverslips were mounted
onto SEM stubs and analyzed using a FEI Magellan 400L SEM.This journal is © The Royal Society of Chemistry 2015
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